Adcendo

Adcendo ApS is a clinical-stage biopharmaceutical company headquartered in Copenhagen, Denmark, with US operations in Boston, Massachusetts, developing a new generation of antibody-drug conjugates (ADCs) for cancers with high unmet medical need. Founded in 2017 out of research by Lars Henning Engelholm and Niels Behrendt, the company advances a clinical and pre-clinical pipeline that includes ADCE-T02 (targeting Tissue Factor, in the Phase 1b Tiffany-01 study across advanced solid tumors), ADCE-D01 (targeting uPARAP, granted FDA Fast Track designation for soft tissue sarcoma), and the pre-clinical ADCE-B05. Adcendo is a privately held, venture-backed therapeutics developer; it publishes a corporate website, pipeline and publications pages, and investor press releases, but it operates no developer program, public API, or machine-readable API contract.

Adcendo is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Life Sciences.

🌐 Visit website 📡 Source on GitHub

8.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyPharmaceuticalsOncologyLife SciencesAntibody-Drug ConjugatesClinical StageDenmark

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 8.5/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Commercial Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/adcendo: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

PressReleases

PressReleases

Contact

Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 4

The organization behind the API

Website

About

BlogRSS

Careers

Other 3

Properties that don't map to a standard resource type

Pipeline

Pipeline

Publications

Publications

CookiePolicy

CookiePolicy

Source (apis.yml)

aid: adcendo
name: Adcendo
description: Adcendo ApS is a clinical-stage biopharmaceutical company headquartered in Copenhagen, Denmark, with US operations
  in Boston, Massachusetts, developing a new generation of antibody-drug conjugates (ADCs) for cancers with high unmet medical
  need. Founded in 2017 out of research by Lars Henning Engelholm and Niels Behrendt, the company advances a clinical and
  pre-clinical pipeline that includes ADCE-T02 (targeting Tissue Factor, in the Phase 1b Tiffany-01 study across advanced
  solid tumors), ADCE-D01 (targeting uPARAP, granted FDA Fast Track designation for soft tissue sarcoma), and the pre-clinical
  ADCE-B05. Adcendo is a privately held, venture-backed therapeutics developer; it publishes a corporate website, pipeline
  and publications pages, and investor press releases, but it operates no developer program, public API, or machine-readable
  API contract.
url: https://raw.githubusercontent.com/api-evangelist/adcendo/refs/heads/main/apis.yml
image: https://adcendo.com/wp-content/uploads/adcendo-logo.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Life Sciences
- Antibody-Drug Conjugates
- Clinical Stage
- Denmark
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/adcendo-domain-security.yml
- type: Website
  url: https://adcendo.com/
- type: About
  url: https://adcendo.com/adcendo/about/about-adcendo/
- type: Pipeline
  url: https://adcendo.com/adcendo/our-science/pipeline/
- type: Publications
  url: https://adcendo.com/adcendo/our-science/key-publications/
- type: PressReleases
  url: https://adcendo.com/adcendo/investors/press-releases/
- type: BlogRSS
  url: https://adcendo.com/feed/
- type: Careers
  url: https://adcendo.com/adcendo/your-careers-and-our-values/
- type: Contact
  url: https://adcendo.com/contact/
- type: PrivacyPolicy
  url: https://adcendo.com/privacy-policy/
- type: CookiePolicy
  url: https://adcendo.com/cookie-policy/
- type: LLMsTxt
  url: llms/adcendo-llms.txt
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Adcendo is a clinical-stage biopharmaceutical company developing antibody-drug conjugates; its only machine-readable
    endpoint is the stock WordPress REST API of its marketing CMS at /wp-json/ (LiteSpeed, Wordfence, Divi and Google Site
    Kit plugin routes), and every OpenAPI, GraphQL, MCP and A2A discovery path on adcendo.com returns 404.
  evidence:
  - url: https://adcendo.com/openapi.json
    status: 404
  - url: https://adcendo.com/graphql
    status: 404
  - url: https://adcendo.com/.well-known/agent-card.json
    status: 404
  - url: https://adcendo.com/.well-known/security.txt
    status: 404
  - url: https://adcendo.com/wp-json/
    status: 200
  checked: '2026-08-06'